BIOFOTCIndustrial Organic ChemicalsFiscal year ends December 31
BLUE BIOFUELS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.11+0.00 (+1.77%)
Close on Oct 19, 2026
- Market cap
- $35.14M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2012 to 2025
Operating margin
–
Net margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -184.1% | 65.4% | 87.7% | |
| Return on assets | -93.2% | -290.4% | -205.6% | |
| Current ratio | 0.20 | 0.30 | 0.03 | |
| Debt to equity | – | – | -0.09 | |
| Net debt to EBITDA | – | – | -0.07× | |
| Diluted shares | 58M | 230M | 312M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Blue Biofuels generated $7.95M from operations and spent $782.42K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$7.95M
Used
$782.42K
Capital expenditure$782.42K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-7640.3%
×Asset turnover0.02×
×Equity multiplier2.22×
=Return on equity, FY2017-335.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2017 | -7640.3% | 0.02× | 2.22× | -335.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$2.87M
- Cash generatingOperating cash flow above zero-$845.00K
- Return on assets improvedROA up on the prior year-137.7% → -206.9%
- Earnings backed by cashOperating cash flow above net income-$845.00K vs -$2.87M
- Less leverageLong-term debt to assets fell23.1% → 22.8%
- Better liquidityCurrent ratio rose0.04 → 0.03
- No dilutionShare count did not rise304M → 312M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –